Symrise invests in enzymatic tech for “rare” sugar alternatives by start-up Bonumose
date:Jul 19, 2023
Strengthening its sugar reduction activities in North America, Symrise has signed a minority investment agreement with Virginia, US-based start-up Bonumose. The early-stage ingredient manufacturer specializes in the affordable production of rare monosaccharides (alternatives to sucrose) such as tagatose and allulose.

In line with this transaction, Symrise is expected to accelerate growth in its sugar reduction initiatives. The area represents a high-priority focus for the flavor houses Taste, N
1/8 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
05/20 16:00